Biomea Fusion, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Biomea Fusion, Inc. (BMEA) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- Biomea Fusion, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$21.00K.
- Biomea Fusion, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$982.00K.
- Biomea Fusion, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$560.00K, a 112.71% decline year-over-year.
- Biomea Fusion, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$5.64M, a 313.35% decline year-over-year.
- Biomea Fusion, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$7.82M, a 201.00% decline from fiscal 2024.
- Biomea Fusion, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $7.74M.
- Biomea Fusion, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$2.48M, a 243.65% decline from fiscal 2022.
- Biomea Fusion, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.73M, a 31.47% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.00M 10-Q · filed 2026-08-05 | -$1.56M derived: sum of 3 quarters · filed 2026-08-05 | -$7.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$982.00K 10-Q · filed 2026-05-11 | -$1.54M derived: sum of 2 quarters · filed 2026-05-11 | -$7.18M derived: sum of 3 quarters · filed 2026-05-11 | -$7.57M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$6.20M derived: sum of 2 quarters · filed 2026-03-24 | -$6.58M derived: sum of 3 quarters · filed 2026-08-05 | -$7.82M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$5.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$6.02M derived: sum of 2 quarters · filed 2026-08-05 | -$7.25M 10-Q · filed 2025-11-04 | -$2.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$382.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.61M 10-Q · filed 2026-08-05 | $2.79M derived: sum of 3 quarters · filed 2026-08-05 | $5.44M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.23M 10-Q · filed 2026-05-11 | $3.17M derived: sum of 2 quarters · filed 2026-05-11 | $5.82M derived: sum of 3 quarters · filed 2026-05-11 | $6.17M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $7.05M derived: sum of 2 quarters · filed 2026-03-24 | $7.41M derived: sum of 3 quarters · filed 2026-03-24 | $7.74M 10-K · filed 2026-03-24 |
| 2024-09-30 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.00M derived: sum of 2 quarters · filed 2025-11-04 | $3.33M 10-Q · filed 2025-11-04 | $2.21M derived: sum of 4 quarters · filed 2026-03-24 |
| 2024-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $687.00K 10-Q · filed 2025-08-05 | -$435.00K derived: sum of 3 quarters · filed 2026-03-24 | -$49.00K derived: sum of 4 quarters · filed 2026-03-24 |
| 2024-03-31 | $333.00K 10-Q · filed 2025-05-05 | -$789.00K derived: sum of 2 quarters · filed 2026-03-24 | -$403.00K derived: sum of 3 quarters · filed 2026-03-24 | $200.00K derived: sum of 4 quarters · filed 2026-03-24 |
| 2023-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$736.00K derived: sum of 2 quarters · filed 2026-03-24 | -$133.00K derived: sum of 3 quarters · filed 2026-03-24 | -$2.48M 10-K · filed 2026-03-24 |
| 2023-09-30 | $386.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $989.00K derived: sum of 2 quarters · filed 2024-10-29 | -$1.36M 10-Q · filed 2024-10-29 | -$1.99M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | $603.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$1.74M 10-Q · filed 2024-07-31 | -$2.38M derived: sum of 3 quarters · filed 2025-03-31 | -$1.48M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | -$2.35M 10-Q · filed 2024-05-02 | -$2.98M derived: sum of 2 quarters · filed 2025-03-31 | -$2.08M derived: sum of 3 quarters · filed 2025-03-31 | $208.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | -$633.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $265.00K derived: sum of 2 quarters · filed 2025-03-31 | $2.55M derived: sum of 3 quarters · filed 2025-03-31 | $1.73M 10-K · filed 2025-03-31 |
| 2022-09-30 | $898.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $3.19M derived: sum of 2 quarters · filed 2023-10-30 | $2.36M 10-Q · filed 2023-10-30 | $3.71M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | $1.46M 10-Q · filed 2023-07-31 | $2.81M derived: sum of 3 quarters · filed 2024-03-28 | $2.56M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | -$828.00K 10-Q · filed 2023-05-02 | $519.00K derived: sum of 2 quarters · filed 2024-03-28 | $268.00K derived: sum of 3 quarters · filed 2024-03-28 | $1.40M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.10M derived: sum of 2 quarters · filed 2024-03-28 | $2.23M derived: sum of 3 quarters · filed 2024-03-28 | $2.52M 10-K · filed 2024-03-28 |
| 2021-09-30 | -$251.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $878.00K derived: sum of 2 quarters · filed 2022-11-07 | $1.17M 10-Q · filed 2022-11-07 | $1.50M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $1.42M 10-Q · filed 2022-08-01 | $1.75M derived: sum of 3 quarters · filed 2023-03-28 | $1.90M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $292.00K 10-Q · filed 2022-05-16 | $617.00K derived: sum of 2 quarters · filed 2023-03-28 | $770.00K derived: sum of 3 quarters · filed 2023-03-28 | $781.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $325.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $478.00K derived: sum of 2 quarters · filed 2023-03-28 | $489.00K derived: sum of 3 quarters · filed 2023-03-28 | $472.00K 10-K · filed 2023-03-28 |
| 2020-09-30 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $164.00K derived: sum of 2 quarters · filed 2021-11-03 | $147.00K 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$6.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$17.00K 10-Q · filed 2021-05-27 | |||
| 2019-12-31 | -$7.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |